What do the steel industry and cutting-edge cancer treatments have in common? According to Hervé Affagard, CEO and co-founder of MaaT Pharma, more than you might think. In this episode, Hervé guides us through his journey from his early days as an engineer pioneering in industrial fields to spearheading the development of microbiome-based therapies for some of the world's most challenging diseases.

Guided by a deeply personal mission inspired by his parents’ battles with cancer, Hervé shares how a revelation about the microbiome over a decade ago changed everything. From the first transformative trials on Clostridium difficile to MaaT Pharma’s work restoring microbial balance to treat graft-versus-host disease, Hervé explains how re-establishing the gut’s ecosystem can enhance immune function and offer new therapeutic possibilities for oncology and beyond.

Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.

Hosted by Jonathan D. Grinstein

Produced by Bill Levine

Audio mixed and mastered by David Mosely

Music provided by penguinmusic

Hosted on Acast. See acast.com/privacy for more information.